Event Information

When the Market Fails: Innovating for Rare and Underserved Patients with Amber Salzman, Ph.D.

Salzman started her career at GSK, working on medicines that reached millions. Then her family was touched by a rare genetic disease, and the gap between what patients need and what the system rewards became impossible to ignore. That experience pushed Salzman into biotechnology leadership, where she focuses on building therapies for people who are too often overlooked. Today, she is working on muscular dystrophy, which currently has no approved treatment, by leveraging next-generation approaches to precisely control gene expression. In this talk, Salzman will share what it takes to turn patient needs into a development strategy, how to make bold technology choices without losing clinical discipline and why the next wave of breakthroughs depends on who gets to innovate.